Plain-English translation of NCT05307731 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether , a medication that's already used for other conditions, might also help people with type 2 diabetes control their blood sugar levels. Researchers want to see if adding this medication to standard diabetes treatment works better than standard treatment alone, and whether it's safe to use this way. They'll measure changes in blood sugar control and how well the pancreas is working.
Type 2 diabetes affects millions of people, and even with current medications, many people still struggle to keep their blood sugar at healthy levels. This study explores whether this medication could be a new tool to help people better manage their diabetes and protect their pancreas's ability to produce insulin.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to either take the new medication ( 0.5mg daily) along with your regular diabetes treatment, or to continue with standard diabetes treatment alone. The researchers will track changes in your blood sugar levels and pancreas function through blood tests measuring hemoglobin A1C, insulin, and C-peptide. You'll be seen at the hospital where the study is taking place for monitoring and follow-up visits.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China